Good news for SENZ, RELV, and CYAN

crwefinancelogo2

signup3m

Sport Endurance, Inc (OTC:SENZ), a health supplement company, announced today that the Company management expects to generate over $7.4 million in sales of its revolutionary Liquid Gel Cap products through 2011. Management believes these figures will surpass $38.7 million in revenues by 2013.

Revenues will be derived from sale of the Company's breakthrough dietary supplements, including; 8 Hour Energy Liquid Gel Caps, Creatine Liquid Gel Caps, Natural Sleep Aid Liquid Gel Caps.

We are confident that we will meet or exceed these sales projections, said Robert Timothy, CEO of Sport Endurance, Inc. Our supplements for building muscle mass, providing 8 hour energy supplements, and sleep aids have been reduced to a tiny gel cap size, represent a revolution in dietary supplements. Our Company is among the first in the exciting Liquid Gel Cap field.

Taking into consideration the unique superiority of our products, the explosive growth of the energy supplement, and energy shot market, and our distribution partnerships and sales force, we believe that these estimates are actually quite conservative.

The market for energy-boosting products has ballooned by more than 400% over the past five years. Sales have grown from $1.2 billion in 2002 to an estimated $6.6 billion in 2007. Market research firm, Packaged Facts, also projects that the energy supplement market will reach $9.3 billion by 2011.

SENZ develops, manufactures, markets, and distributes, quality dietary supplements products throughout the United States. SENZ believes that improved health contributes to, and promotes a higher quality of life. It is SENZs goal to improve health by providing quality and effective nutritional supplements with their state of the art liquid gel cap delivery system. All Sport Endurance brand products are manufactured within the USA in FDA inspected facilities. SENZ primary focus is on three areas of health that most directly impact the lives of most Americans; energy/weight loss, muscle growth and maintenance, and sleep aid/relaxation.

Reliv International, Inc. (Nasdaq:RELV) is a developer, manufacturer and marketer of a proprietary line of nutritional supplements. Reliv supplements address essential daily nutrition, weight loss and targeted solutions such as energy and performance enhancement, digestive health, women's health and anti-aging. Reliv sells its products through an international network marketing system of approximately 64,000 independent distributors.

Reliv International, Inc. a nutritionand direct selling company, recently reported consolidated net sales of $18.8 million for the second quarter
of 2010, compared to net sales of $20.1 million in the second quarter of last year. International sales rose 18.7 percent compared to the same quarter in 2009, but U.S. sales were down 9.5 percent in the quarter.

Net income was $206,000 compared to net income of $410,000 in the second quarter of last year. Diluted earnings per share totaled $0.02 in the second quarter this year compared to $0.03 in the same quarter last year.

U.S. sales for the quarter totaled approximately $15.9 million compared to $17.6 million in the second quarter of 2009. Sales outside of the U.S. rose to approximately $2.9 million compared to net sales of approximately $2.4 million in last year's second quarter. In local currencies,international sales rose 11.3 percent in the second quarter compared to the same quarter last year. Sales outside of the U.S. account for 15 percent of net sales.

Cyanotech Corporation (Nasdaq:CYAN), a world leader in microalgae-based, high-value nutrition and health products, recently reported that it had received notice from the Nasdaq Stock Market on June 30, 2010 of full compliance with Listing Rules required for its continued listing on the The Nasdaq Capital Market.

On March 8, 2010, Nasdaq issued a non-compliance notice to the Company given the appointment of David I. Rosenthal as Interim President and CEO and his concurrent resignation from the Audit Committee of the Board of Directors due to his temporary executive position. The non-compliance notice was due to the Board having fewer than three independent directors on its audit committee and having less than a majority of non-executive, independent directors. On March 31, 2010, the Board was restored to compliance upon the resignation from the Board by the prior President and CEO, leaving a majority of non-executive, independent directors plus only two executive directors. On June 23, 2010, the Board of Directors appointed Michael A. Davis, an independent director, to the Audit Committee. Upon its notification of this action to Nasdaq, the Company completed its requirements for return to full compliance.

CYAN engages in the cultivation, production, and sale of natural products derived from microalgae worldwide. It offers BioAstin natural astaxanthin, a dietary antioxidant for use as a human nutraceutical and functional food ingredient to support and maintain the body's natural inflammatory response, as well as to enhance skin, muscle, and joint health.

http://crwefinance.com/img/crwefinance_new_buscard2.jpg

Signup for FREE Daily Stock Alerts From CRWEFinance.com/signup

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWEFinance.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWEFinance.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (read more ) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (CRWE.OB) has received ten thousand dollars from a third party (Stienhoff Limited) for two days of advertising for Sport Endurance, Inc. (OTCBB: SENZ)